A pH-sensitive alginate-coated ZIF-8 carrier protects Cycloheptylamine hydrochloride in the stomach and releases it in the intestines.
Small-molecule aminoethyl Schiff bases target PD-1/PD-L1 to improve tumor penetration and lower cost versus monoclonal antibodies.